Docs Who Lift-logo

Docs Who Lift

Medical

Drs. Spencer and Karl Nadolsky talk about nutrition, medicine, and fitness through the lens of two physicians who lift weights. Both doctors are former NCAA division 1 wrestlers who have gone into medicine. Dr. Spencer Nadolsky is a board certified family physician specialized in obesity medicine and lipidology. Dr. Karl Nadolsky is a board certified endocrinologist also specialized in obesity medicine.

Location:

United States

Description:

Drs. Spencer and Karl Nadolsky talk about nutrition, medicine, and fitness through the lens of two physicians who lift weights. Both doctors are former NCAA division 1 wrestlers who have gone into medicine. Dr. Spencer Nadolsky is a board certified family physician specialized in obesity medicine and lipidology. Dr. Karl Nadolsky is a board certified endocrinologist also specialized in obesity medicine.

Language:

English


Episodes
Ask host to enable sharing for playback control

The Truth About Creatine (Doctors Discuss)

3/6/2026
Takeaways: Creatine is a naturally occurring compound that helps regenerate ATP, the energy currency of the cell. Supplementing with creatine can enhance performance in high-intensity exercise but may not be beneficial for endurance activities. The majority of creatine is stored in muscle, and supplementation can help fill those stores for better energy availability. Creatine monohydrate is the most studied and effective form of creatine, and it's also the cheapest. There is no need to cycle creatine; continuous use is safe and effective. Creatine supplementation is generally safe, but individuals should inform their healthcare providers about its use. The benefits of creatine are most pronounced in individuals engaging in high-intensity exercise. Creatine does not directly build muscle; it requires exercise to be effective. There is a misconception that creatine is harmful to the kidneys; it is safe for healthy individuals. Creatine supplementation may have potential cognitive benefits, but more research is needed. Follow Dr. Lauren Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Duration:00:35:06

Ask host to enable sharing for playback control

Top Sleep Doctor: Stop Taking Melatonin Like This

2/23/2026
Takeaways: The 11-Minute Rule: Why blue light isn't the villain you think it is. The Melatonin Mistake: Why "less is more" (and the exact dosage for success). Trackers vs. Reality: When to throw away your Apple Watch or Oura Ring. The Bedrock Principle: Why sleep is the lead domino for fat loss and metabolic health. Sex & Sleep: The surprising biological difference in how men and women recover. Tap Here to follow Shelby Shelbys Book Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Duration:00:48:33

Ask host to enable sharing for playback control

GLP-1s and Fertility What to Know Before Trying to Conceive

2/12/2026
Get The Lucky Egg Book Here Takeaways: Dr. Lucky Sekhon is a reproductive endocrinologist and author of 'The Lucky Egg'. The pathway to reproductive endocrinology involves extensive training in OB-GYN and specialized fellowship. Social media became a tool for Dr. Sekhon to combat misinformation during the pandemic. Common myths in fertility include the idea that one can reverse the biological clock. Understanding the fertility knowledge gap is crucial for patients seeking help. Insulin resistance plays a significant role in fertility issues, especially in women with PCOS. Fertility treatments should be evidence-based and tailored to individual needs. GLP-1 medications can help regulate menstrual cycles and improve fertility outcomes. Endometriosis can significantly impact fertility and requires tailored treatment approaches. The importance of patient education in navigating fertility treatments cannot be overstated. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Duration:00:54:19

Ask host to enable sharing for playback control

Reclaiming Excellence: A Conversation with Brad Stolberg

1/30/2026
Takeaways Excellence is not a standard but a process of becoming. Involved engagement means caring deeply about what you do. The pursuit of excellence shapes you into a better person. Consistency is key to achieving long-term goals. It's important to align your pursuits with your values. Youth sports can be beneficial but also harmful if not approached correctly. Weight loss should shift from a focus on numbers to health and well-being. Building a diverse identity can help prevent burnout in athletes. The transition out of sports can be challenging due to identity loss. Enjoying the process is more fulfilling than the end goal. Tap or Click Here to Buy Brads Book Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Duration:00:45:13

Ask host to enable sharing for playback control

Oral GLP-1 (Wegovy) Is Here: Dosing, Switching, and What to Expect

1/20/2026
Key Episode Takeaways Oral Wegovy is real, but it’s not “just a pill version of the shot.” Absorption rules, dosing schedules, and patient selection matter a lot more than most headlines suggest. Switching from injections to oral GLP-1s requires a plan. The transition isn’t one-size-fits-all, and dose timing, GI tolerance, and expectations need to be managed carefully. Weight regain after stopping GLP-1s is common, but not universal. SURMOUNT-4 data shows large variability, reinforcing that biology, not willpower, drives outcomes. Maintenance matters as much as weight loss. Some patients need continued therapy at lower doses, while others may maintain with lifestyle plus strategic medication use. Stopping abruptly is usually the worst approach. Gradual transitions and realistic long-term strategies reduce rebound weight gain. GLP-1s are chronic disease tools, not short-term fixes. Treating obesity like hypertension or diabetes leads to better outcomes and fewer surprises. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Duration:00:25:23

Ask host to enable sharing for playback control

Breaking Down the New Food Pyramid (Great or Confusing)

1/12/2026
Takeaways: Dietary guidelines have evolved since the 1980s. The food pyramid was introduced in 1992 and has influenced public perception. New dietary guidelines emphasize healthy fats but retain some old recommendations. There are contradictions in the new guidelines regarding saturated fat and protein intake. The definition of processed foods remains vague and controversial. The guidelines are intended for healthcare professionals, not consumers. Public policy needs to align with dietary guidelines for effective implementation. The emphasis on real food is not a new concept in dietary guidelines. There is skepticism about whether the new guidelines will lead to meaningful changes in public health. The conversation around dietary guidelines is often politically charged. Follow Kevin: Tap Here Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Duration:00:29:55

Ask host to enable sharing for playback control

Cortisol Myths vs Reality: What Your Adrenals Actually Do

1/7/2026
Takeaways: Cortisol is essential for various bodily functions, especially during stress. Adrenal glands have a circadian rhythm that affects cortisol production. Cushing's syndrome can result from excess cortisol and has specific symptoms. Diagnosis of adrenal disorders requires careful testing and consideration of symptoms. Mild autonomous cortisol secretion can complicate diabetes management. The Catalyst trial explored the effects of cortisol antagonism on diabetes. Future research may focus on selective glucocorticoid receptor modulators. Woolly mammoth studies provide insights into historical testosterone levels. Understanding adrenal health is crucial for effective patient care. Endocrinologists must navigate the complexities of hormone testing and treatment. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Duration:01:03:28

Ask host to enable sharing for playback control

GLP-1 Side Effects Deep Dive: Slimmer's Paralysis, Bladder Spasms, & Reactive Hypoglycemia.

12/5/2025
Takeaways: Slimmer's Paralysis is a recognized condition. Ethical boundaries are crucial in patient relationships. Medical professionals must maintain professionalism at all times. Humor can sometimes arise in serious discussions. Patient stories should always be handled with care. The importance of clear communication in medical settings. Understanding patient experiences is vital for effective care. Ethics in medicine is a complex and nuanced topic. Medical discussions can lead to unexpected topics. Maintaining a professional demeanor is essential. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Duration:00:31:54

Ask host to enable sharing for playback control

GLP-1s and Breast Milk: What the New Research Actually Found

11/19/2025
Takeaways: Drug transfer during lactation is complex and challenging. Semaglutide was not detected in women taking any dose. Low amounts of tears epitide were found in milk. Tissue damage can affect drug absorption. Mastitis and engorgement complicate the lactation process. Injections are necessary for effective drug delivery. The analogy of an elephant illustrates the difficulty of drug transfer. Detection of drugs in milk is a critical concern for breastfeeding mothers. Understanding turnover is essential in lactation studies. The implications of drug transfer on women's health are significant. Infant Risk Center Link Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Duration:00:34:08

Ask host to enable sharing for playback control

How to Build Healthy Routines That Actually Stick

11/12/2025
Takeaways: Behavior change is a complex process that requires understanding motivation and discipline. Motivation is not just a feeling; it's a psychological skill that can be developed. Many common phrases about behavior change are misleading and oversimplified. Exercise should be viewed as a choice rather than a habit that becomes automatic. Self-efficacy is crucial for successful behavior change and can be built through mastery experiences. Future self thinking can help individuals align their actions with their long-term goals. It's important to lower barriers to entry for new behaviors to increase adherence. Modeling healthy behaviors is essential for influencing children and adolescents. The psychological definition of a habit differs from the colloquial use of the term. Resources and support systems are vital for individuals looking to change their behaviors. Follow Dr. Nordin Here Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Duration:00:35:23

Ask host to enable sharing for playback control

The Truth About Testosterone Therapy in Women (with Dr. Susan Davis)

11/3/2025
Tap to Follow Dr.Susan Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Duration:01:00:56

Ask host to enable sharing for playback control

From Injections to Pills: Breaking Down the New Oral GLP-1 Data

10/23/2025
Show Notes: In this episode of Docs Who Lift, the Nadolsky brothers welcome back Dr. Sean Wharton, clinical trialist and one of the leading researchers behind the next generation of oral GLP-1 medications. Together, they break down: The OASIS-4 trial results on 25mg oral semaglutide and how it stacks up to injectable Wegovy How orforglipron, Eli Lilly’s new small-molecule GLP-1, differs from peptide-based drugs Why these new therapies could make weight management more accessible and affordable The fascinating pharmacology behind “snack molecules” and small-molecule receptor agonists Common misconceptions about bioavailability, dosing, and side effects The potential role of oral GLP-1s for patients with mild obesity or cardiometabolic disease Whether you’re a clinician, researcher, or patient curious about the future of obesity medicine, this conversation offers a clear look at how science is shifting toward needle-free solutions. Oasis 1 Trial Link Oasis 4 Trial Link Attain 1 Trial Link Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Duration:00:32:01

Ask host to enable sharing for playback control

De-Emphasizing BMI, Prioritizing Health: What’s New in the ACE Obesity Guidelines

10/13/2025
In this episode of Docs Who Lift, the Nadolsky brothers dive deep into the newly released American Association of Clinical Endocrinology (ACE) Algorithm for Obesity Care led by Dr. Karl himself. They explore: Why ACE moved away from a BMI-only approach to a person-centered, complication-centric model The new staging framework (ABCD) that helps individualize treatment intensity How to interpret “clinical” vs “preclinical” obesity under the new model Updated targets for clinically meaningful weight loss (5%, 10%, 15% tiers) The emphasis on resistance training, sleep, and behavioral health alongside nutrition Practical guidance for selecting anti-obesity medications and identifying the right therapy for each patient Whether you’re a clinician, health professional, or patient trying to understand modern obesity care, this episode breaks it all down in a practical, real-world way without the jargon. Youtube Video to follow along the graphic mentioned Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Duration:00:48:03

Ask host to enable sharing for playback control

Debunking The Myths of Metabolism and Weight Loss

9/25/2025
Takeaways Julia Belluz X/Twitter Kevin Hall X/Twitter Purchase Their Book Here Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Duration:00:57:56

Ask host to enable sharing for playback control

Menopause Medicine Meets Obesity Care: Doctors React

9/1/2025
Takeaways Menopausal women often prioritize weight gain concerns over other symptoms. The study observed an association between hormone therapy and weight loss with GLP-1 medications. Retrospective studies have limitations but can provide valuable insights. Future research should focus on randomized controlled trials to confirm findings. The relationship between estrogen and GLP-1 signaling needs further exploration. Funding for research can be challenging, especially for early career investigators. Collaboration between different specialties is crucial for comprehensive patient care. The media often misrepresents research findings, leading to misconceptions. Individualized treatment plans are essential for menopausal women. There is a need for more awareness about the effects of menopause on health. Research Links: Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Duration:00:39:26

Ask host to enable sharing for playback control

Women’s Fitness Needs Debate: Dr. Stacey Sims vs. Dr. Lauren Colenso-Semple

8/29/2025
Takeaways - Women are not just smaller versions of men; their training and nutrition needs differ significantly. - Fasted training can lead to hormonal and metabolic changes that may not be beneficial for women. - Post-workout nutrition timing is crucial for women to optimize muscle growth and recovery. - Strength training for women should focus on heavier loads and lower reps, especially during perimenopause. - The menstrual cycle can influence training, but individual responses vary widely among women. - Consistency in training is more important than adhering to strict phase-based training protocols. - Women often miss eating opportunities post-exercise, which can hinder their progress. - Research on women's health is still evolving, and more diverse studies are needed. - Understanding the hormonal changes during perimenopause is essential for effective training. Practical application of scientific findings is crucial for helping women achieve their fitness goals. Tap Here for Dr Stacy Sims References Tap Here for Dr. Colenso-Semples References Dr. LCS Instagram Dr. SS Instagram

Duration:01:07:13

Ask host to enable sharing for playback control

Do You Really Lose Muscle on Semaglutide or Tirzepatide?

8/22/2025
Takeaways Tap or Click here to see more from Dr. Grant Tap here for scientific references in this episode.

Duration:00:33:50

Ask host to enable sharing for playback control

Predatory Lab Testing: What They’re Not Telling You

8/16/2025
Takeaways Direct-to-consumer lab testing is on the rise, with significant marketing efforts behind it. Many patients feel brushed off by traditional healthcare providers, leading them to seek alternative testing options. Communication between patients and healthcare providers is often inadequate, contributing to misunderstandings about health. Over-testing can lead to unnecessary anxiety and misinterpretation of results. Fitness influencers often promote lab testing without proper medical training, which can be harmful. There is a need for ethical practices in lab testing and patient care. Patients should be cautious of companies that upsell supplements based on lab results. The healthcare system often fails to provide adequate time for patient concerns to be addressed. Understanding lab results requires skilled interpretation, which is often lacking in direct-to-consumer models. A collaborative approach among healthcare professionals is necessary to improve patient outcomes. Click to join Dr. Spencer's online clinic if you need help with this Click here to check out Barbell Medicine

Duration:00:49:50

Ask host to enable sharing for playback control

CVS Pulled the Plug on Zepbound?!

8/8/2025
In this episode of the Dr. Lift podcast, hosts Dr. Spencer Nadolsky and Dr. Karl discuss the recent changes in obesity medication coverage, particularly focusing on the CVS Caremark decision to drop ZEPBound from their formulary in favor of Wegovi. They explore the implications of this decision for patients and providers, the role of pharmacy benefit managers (PBMs) in healthcare, and the ongoing advocacy efforts to ensure access to effective obesity treatments. The conversation highlights the complexities of insurance coverage, the need for patient-centered care, and the importance of making medications more affordable. - The recent changes in obesity medication coverage have raised concerns among providers and patients. - CVS Caremark's decision to drop ZEPBound has sparked a petition advocating for better access to medications. - Pharmacy Benefit Managers (PBMs) play a significant role in determining medication coverage and costs. - There is a need for more nuanced insurance policies that consider patient needs and clinical severity. - Advocacy efforts are crucial in reversing negative trends in medication coverage. - Patients often face challenges with prior authorization processes when switching medications. - The cost of obesity medications is a significant barrier to access for many patients. - Insurance companies are increasingly dropping coverage for anti-obesity medications, impacting patient care. - The conversation emphasizes the importance of patient-centered care in obesity treatment. - There is a call for making obesity medications more affordable and accessible to patients. https://www.change.org/p/stop-cvs-caremark-s-zepbound-ban-restore-coverage-of-the-superior-obesity-medication Click to join Dr. Spencer's online clinic if you need help with this

Duration:00:20:12

Ask host to enable sharing for playback control

More Than Weight Loss? GLP-1s and Cardiovascular Risk

8/3/2025
In this episode of the Dr. Lift podcast, hosts Dr. Spencer Nadolsky and Dr. Karl discuss the Surpass CVOT trial, which evaluates the cardiovascular outcomes of Monjaro compared to Dulaglutide (Trulicity). They delve into the significance of the trial, the implications of the results, and the potential benefits of Monjaro for patients with type 2 diabetes and cardiovascular risks. The conversation highlights the importance of understanding cardiovascular outcome trials and the evolving landscape of diabetes medications. Takeaways: The Surpass CVOT trial compares Mounjaro to Dulaglutide. Dulaglutide has shown cardiovascular benefits in previous trials. The trial results indicate Monjaro is at least not inferior to Dulaglutide. There is a trend towards better cardiovascular outcomes with Mounjaro. Weight loss and glycemic control are significant benefits of Mounjaro. The trial did not include a placebo, but used a putative analysis. The results are reassuring for patients at high cardiovascular risk. The conversation emphasizes the importance of comprehensive treatment for metabolic diseases. The hosts express enthusiasm for the potential of Mounjaro. Future discussions will delve deeper into the trial's findings.

Duration:00:11:16